‘Active' Mom of 2 Had No Symptoms Before Sudden ‘Agonizing Pain' in Her Chest Led to Shocking Diagnosis
Sharon Smith, from Liverpool, England, was diagnosed with an acute form of leukemia after experiencing chest pain
The mom of 2 said the diagnosis came as a "complete shock" as she had "no symptoms" before returning from vacation
"I'd been playing football in the garden with my little grandson the night before I got this pain," Smith said in Clatterbridge Cancer Centre's news releaseA woman in England had "no symptoms at all" before a sudden pain in her chest led to a devastating diagnosis.
Sharon Smith, from Liverpool, went to a local emergency room after she began to experience "an agonizing pain in her chest" in April 2023, according to a news release shared by the city's Clatterbridge Cancer Centre, which is where she was initially treated.
Following blood tests and a bone marrow biopsy, the mother of two was diagnosed with acute lymphoblastic leukemia (ALL).
"It came as a complete shock," Smith said, per the news release.
Acute lymphocytic leukemia — also known as acute lymphoblastic leukemia — "is a type of cancer of the blood and bone marrow — the spongy tissue inside bones where blood cells are made," according to the Mayo Clinic.
"The word 'acute' in acute lymphocytic leukemia comes from the fact that the disease progresses rapidly and creates immature blood cells, rather than mature ones," the organization states.
Smith — who lives with her husband, Paul, and has two sons and a grandson — said she had "no symptoms at all" before the shocking cancer diagnosis.
"We'd just come back from [vacation] where I'd walked the length of Spain and I'd been playing football in the garden with my little grandson the night before I got this pain," she recalled, per the Clatterbridge Cancer Centre's news release.
Smith was sent to the Clatterbridge Cancer Centre for chemotherapy following the diagnosis. In November 2023, she then underwent a "stem cell transplant from a donor to help her create healthy new blood cells and reduce the risk of the cancer returning," according to the news release.
'I felt really good after the stem cell transplant,' Smith said. 'I've always been on the go, really active and busy, and I felt like my usual self again."
'I was still coming for regular check-ups at Clatterbridge and, in September 2024, my routine bone marrow biopsy showed I had relapsed and the cancer was back. I just wasn't expecting it so, as you can imagine, I was completely shocked," she continued.
'That was a Tuesday and I went home thinking this was the end for me, then on the Friday I got a lovely phone call from the consultant, Dr. Saif, to say he'd been working behind the scenes to try and find another treatment for me and I'd been accepted for CAR-T therapy," she added, referencing the chimeric antigen receptor T cell therapy, which is a highly innovative form of immunotherapy, per the hospital.
According to the American Cancer Society, CAR-T therapy "is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells."
"This type of treatment can be very helpful in treating some types of cancer, even when other treatments are no longer working," according to the society.
Speaking about being accepted for the treatment, Smith said, 'I went from literally the worst time in life to feeling like I'd just won the lottery because there was a little bit of hope there," per the news release.
Due to CAR-T therapy not being available in Liverpool until the end of 2024, Smith was referred to The Christie in Manchester for her to receive treatment as soon as possible.
She said the approximately 34-mile journey to Manchester was "exhausting," adding, "We were over and back about 20 times in all for consultations, cell collection, chemotherapy, infusion and follow-up appointments afterwards."
Never miss a story — sign up for to stay up-to-date on the best of what PEOPLE has to offer, from celebrity news to compelling human interest stories.
Smith also had to stay in the city for three and a half weeks "during the most intensive stage of treatment."
Having gone to Manchester to have T cells taken from her blood, Smith's cells were then taken to a specialist pharmaceutical laboratory to be transformed into a "unique" CAR-T treatment.
She then had to undergo chemotherapy in Manchester to prepare her body before the treatment began.
Despite some side effects, the treatment was successful and Smith "recovered quickly," according to the hospital's news release. "Her bone marrow biopsies and blood tests are looking good and she is hopeful for what the future will bring," per the news release.
Read the original article on People
Solve the daily Crossword
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Yahoo
9 minutes ago
- Yahoo
GSK climbs after winning FDA priority review for oral gonorrhoea antibiotic
-- GSK (NYSE:GSK) (LON:GSK) said on Monday that the U.S. Food and Drug Administration has accepted its priority review application for gepotidacin, an oral antibiotic aimed at treating sexually transmitted uncomplicated gonorrhoea. The drugmaker's shares climbed 1% in London on the news. The company is looking to new infectious disease products, including its recently launched respiratory syncytial virus vaccine, to offset expected revenue declines from top-selling medicines and looming patent expirations in its HIV portfolio. Gepotidacin is already approved in the U.S. under the brand name Blujepa for treating a common urinary tract infection in women and adolescent girls. The FDA is expected to decide in December on its use for uncomplicated urogenital gonorrhoea, which could offer patients an oral alternative to existing injectable treatments. Separately, GSK and Germany's CureVac last week resolved a long-running patent dispute with Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) over mRNA vaccine technology used during the COVID-19 pandemic. The settlement follows BioNTech's June agreement to acquire CureVac in an all-stock deal worth $1.25 billion to advance work on mRNA-based cancer therapies. Under the settlement, CureVac and GSK will receive $740 million and single-digit percentage royalties on future U.S. sales of COVID-19 vaccines, CureVac said. GSK's share amounts to $370 million, including $50 million to adjust terms from a 2024 licence agreement that expanded their pandemic-era partnership. If BioNTech's takeover of CureVac is completed, related mRNA litigation outside the U.S. will also be resolved, with GSK receiving an additional $130 million and royalties extended to non-U.S. sales. CureVac said the acquisition remains on track under the agreed terms. GSK said it still has separate patent cases against Pfizer and BioNTech in the U.S. and Europe, which are unaffected by this settlement. Related articles GSK climbs after winning FDA priority review for oral gonorrhoea antibiotic USPS blocks major vape distributor over unregulated product shipments - Reuters Exclusive: Opendoor CEO Wheeler breaks silence, EMJ's Eric Jackson calls for more Sign in to access your portfolio
Yahoo
2 hours ago
- Yahoo
All of the County Durham businesses hit with one and zero star hygiene rating in 2025
A number of businesses across County Durham have received low hygiene ratings so far in 2025. Several establishments have been advised to undertake significant improvements to meet acceptable hygiene levels. These ratings are regularly updated and assess key areas including cleanliness and safety, structural compliance, and the management's ability to maintain hygiene standards. Every food-serving venue in the UK—from convenience stores and restaurants to hospitals and care homes—is subject to this rating system. Read more: Two taken to hospital as police close County Durham A-road after crash Almost 400 residents object to 600-home estate in 'bursting at the seams' town Tragedy as body found in search for missing County Durham man James Allen In the North East and North Yorkshire, the vast majority of takeaways and restaurants continue to receive a rating of three or above. But, there are a number that are identified as causes for concern which must either make "urgent" or "major" improvements. What each hygiene rating means: 0 - Urgent Improvement Necessary 1 - Major Improvement Necessary 2 - Some Improvement Necessary 3 - Hygiene Standards Generally Satisfactory 4 - Hygiene Standards Good 5 - Hygiene Standards Very Good We've rounded up the inspections carried out in 2025 from the ratings that have been published by the Food Standards Agency in County Durham. One Star: Aleeza's 10 King Street, Spennymoor, DL16 6QQ Last inspection: 13 February 2025 Alhambra Curry House 7 Alhambra Terrace, Fishburn, TS21 4BU Last inspection: 8 January 2025 Derwentside Pizzas 29 Front Street, Consett, DH8 5AB Last inspection: 8 May 2025 Fox Street Convenience Store 26A Fox Street, Dawdon, SR7 7LL Last inspection: 10 June 2025 Lebaneat 47 North Bailey, Durham, DH1 3ET Last inspection: 11 June 2025 Maan Brothers 87-89 Commercial Street, Willington, DL15 0AA Last inspection: 19 June 2025 Peterlee Lodge Hotel Bede Way, Peterlee, SR8 1BU Last inspection: 5 March 2025 The Flintlock Inn and Café 48 High Street, West Cornforth, DL17 9HS Last inspection: 21 March 2025 The Royal George 16 The Village, Old Shotton, SR8 2ND Last inspection: 17 March 2025 Zero stars: Pizza Bella LB LTD 64 Front Street East, Haswell, DH6 2BL Last inspection: 16 May 2025 The Shake Shack Shildon 34 Church Street, Shildon, DL4 1DX Last inspection: 8 May 2025 *All ratings are as listed by the FSA on its website as of Friday, August 8, 2025.
Yahoo
2 hours ago
- Yahoo
Yellow heat health alert in place for Watford from today
Watford residents have been warned over heat-related risks in an alert starting today. The UK Health Security Agency has announced a yellow heat health alert for the East of England which is due to start at 12pm (August 11) and last until 6pm on August 13. It comes as the Met Office expects temperatures in Watford to reach 30C this afternoon and 33C on Tuesday. The warning also covers London, Yorkshire and the Humber, the East Midlands, the South East and South West. It means there could be a significant impact across health and social care services, including the potential for a rise in deaths, particularly among those aged 65 and over or with health Office meteorologist Tom Morgan said: '[There is] definitely a north-south split in the weather [on Monday]. 'Quite cloudy across Scotland, Northern Ireland and parts of northern England, the rain tending to come and go, but most persistent in western Scotland. 'Otherwise, England and Wales seeing mostly sunny skies, although there will be more in the way of high level cloud out there compared to on Sunday, so the sunshine [will be] hazy at times.'